Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Sees Significant Decline in Short Interest

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) saw a significant decline in short interest in June. As of June 15th, there was short interest totaling 15,401 shares, a decline of 79.5% from the May 31st total of 74,992 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average daily volume of 457,076 shares, the days-to-cover ratio is presently 0.0 days.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on SGIOY. The Goldman Sachs Group raised Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a report on Monday, June 15th. Zacks Research upgraded Shionogi & Co., Ltd. Unsponsored ADR from a “strong sell” rating to a “hold” rating in a research report on Monday, May 25th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, Shionogi & Co., Ltd. Unsponsored ADR presently has a consensus rating of “Buy”.

Shionogi & Co., Ltd. Unsponsored ADR Price Performance

Shares of SGIOY traded up $0.17 during mid-day trading on Friday, reaching $8.52. 272,160 shares of the stock traded hands, compared to its average volume of 206,524. The company has a market cap of $14.50 billion, a price-to-earnings ratio of 10.65, a price-to-earnings-growth ratio of 3.20 and a beta of 0.08. Shionogi & Co., Ltd. Unsponsored ADR has a 1 year low of $7.65 and a 1 year high of $12.00. The firm has a fifty day moving average price of $9.30 and a 200 day moving average price of $9.89. The company has a current ratio of 1.58, a quick ratio of 1.46 and a debt-to-equity ratio of 0.01.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last issued its quarterly earnings data on Tuesday, May 12th. The company reported $0.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.15 by $0.03. The company had revenue of $881.71 million for the quarter, compared to the consensus estimate of $895.52 million. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 13.56% and a net margin of 41.08%. As a group, equities research analysts predict that Shionogi & Co., Ltd. Unsponsored ADR will post 0.81 earnings per share for the current year.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.